166 related articles for article (PubMed ID: 35182276)
1. Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients.
Allahloubi NMA; Zekri AN; Ragab M; Mohanad M; Ahmed OS; Eid S; Ghareeb M; Gouda I; Bahnassy AA
Biochem Genet; 2022 Dec; 60(6):1963-1985. PubMed ID: 35182276
[TBL] [Abstract][Full Text] [Related]
2. Impact of estrogen receptor α on the tamoxifen response and prognosis in luminal-A-like and luminal-B-like breast cancer.
Babyshkina N; Vtorushin S; Dronova T; Patalyak S; Slonimskaya E; Kzhyshkowska J; Cherdyntseva N; Choynzonov E
Clin Exp Med; 2019 Nov; 19(4):547-556. PubMed ID: 31562548
[TBL] [Abstract][Full Text] [Related]
3. The distribution pattern of ERα expression, ESR1 genetic variation and expression of growth factor receptors: association with breast cancer prognosis in Russian patients treated with adjuvant tamoxifen.
Babyshkina N; Vtorushin S; Zavyalova M; Patalyak S; Dronova T; Litviakov N; Slonimskaya E; Kzhyshkowska J; Cherdyntseva N; Choynzonov E
Clin Exp Med; 2017 Aug; 17(3):383-393. PubMed ID: 27225751
[TBL] [Abstract][Full Text] [Related]
4. ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Harvey V; Neven P; Arnould L; Maibach R; Price KN; Coates AS; Goldhirsch A; Gelber RD; Pagani O; Viale G; Rae JM; Regan MM;
Breast Cancer Res Treat; 2015 Dec; 154(3):543-55. PubMed ID: 26590813
[TBL] [Abstract][Full Text] [Related]
5. A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
Li T; Zhao J; Yang J; Ma X; Dai Q; Huang H; Wang L; Liu P
PLoS One; 2016; 11(4):e0153314. PubMed ID: 27070141
[TBL] [Abstract][Full Text] [Related]
6. Variants of estrogen-related genes and breast cancer risk in European and African American women.
Quan L; Hong CC; Zirpoli G; Roberts MR; Khoury T; Sucheston-Campbell LE; Bovbjerg DH; Jandorf L; Pawlish K; Ciupak G; Davis W; Bandera EV; Ambrosone CB; Yao S
Endocr Relat Cancer; 2014; 21(6):853-64. PubMed ID: 25228414
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor alpha polymorphisms: correlation with clinicopathological parameters in breast cancer.
Anghel A; Raica M; Narita D; Seclaman E; Nicola T; Ursoniu S; Anghel M; Popovici E
Neoplasma; 2010; 57(4):306-15. PubMed ID: 20429621
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1).
Najim O; Huizing M; Papadimitriou K; Trinh XB; Pauwels P; Goethals S; Zwaenepoel K; Peterson K; Weyler J; Altintas S; van Dam P; Tjalma W
Cancer Treat Res Commun; 2019; 19():100123. PubMed ID: 30826563
[TBL] [Abstract][Full Text] [Related]
9. The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer.
Vitale SR; Ruigrok-Ritstier K; Timmermans AM; Foekens R; Trapman-Jansen AMAC; Beaufort CM; Vigneri P; Sleijfer S; Martens JWM; Sieuwerts AM; Jansen MPHM
BMC Cancer; 2022 Feb; 22(1):165. PubMed ID: 35151276
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.
Kim C; Tang G; Pogue-Geile KL; Costantino JP; Baehner FL; Baker J; Cronin MT; Watson D; Shak S; Bohn OL; Fumagalli D; Taniyama Y; Lee A; Reilly ML; Vogel VG; McCaskill-Stevens W; Ford LG; Geyer CE; Wickerham DL; Wolmark N; Paik S
J Clin Oncol; 2011 Nov; 29(31):4160-7. PubMed ID: 21947828
[TBL] [Abstract][Full Text] [Related]
11. Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis.
Li N; Dong J; Hu Z; Shen H; Dai M
Breast Cancer Res Treat; 2010 May; 121(1):177-84. PubMed ID: 19760036
[TBL] [Abstract][Full Text] [Related]
12. Impact of ESR1 Polymorphisms on Risk of Breast Cancer in the Chinese Han Population.
Yang W; He X; He C; Peng L; Xing S; Li D; Wang L; Jin T; Yuan D
Clin Breast Cancer; 2021 Jun; 21(3):e235-e242. PubMed ID: 33281037
[TBL] [Abstract][Full Text] [Related]
13. The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival.
Houtsma D; de Groot S; Baak-Pablo R; Kranenbarg EM; Seynaeve CM; van de Velde CJH; Böhringer S; Kroep JR; Guchelaar H-; Gelderblom H
Sci Rep; 2021 Feb; 11(1):3249. PubMed ID: 33547330
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients.
Markiewicz A; Wełnicka-Jaśkiewicz M; Skokowski J; Jaśkiewicz J; Szade J; Jassem J; Zaczek AJ
PLoS One; 2013; 8(8):e72219. PubMed ID: 23951298
[TBL] [Abstract][Full Text] [Related]
15. Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer.
Nielsen KV; Ejlertsen B; Müller S; Møller S; Rasmussen BB; Balslev E; Lænkholm AV; Christiansen P; Mouridsen HT
Breast Cancer Res Treat; 2011 Jun; 127(2):345-55. PubMed ID: 20556506
[TBL] [Abstract][Full Text] [Related]
16. Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer.
Rezende LM; Marson FA; Lima CS; Bertuzzo CS
Gene; 2017 Apr; 608():73-78. PubMed ID: 28109853
[TBL] [Abstract][Full Text] [Related]
17. Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues.
Toussaint J; Sieuwerts AM; Haibe-Kains B; Desmedt C; Rouas G; Harris AL; Larsimont D; Piccart M; Foekens JA; Durbecq V; Sotiriou C
BMC Genomics; 2009 Sep; 10():424. PubMed ID: 19744330
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha (ERS1) SNPs c454-397T>C (PvuII) and c454-351A>G (XbaI) are risk biomarkers for breast cancer development.
Madeira KP; Daltoé RD; Sirtoli GM; Carvalho AA; Rangel LB; Silva IV
Mol Biol Rep; 2014 Aug; 41(8):5459-66. PubMed ID: 24928087
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients.
Hato Y; Kondo N; Yoshimoto N; Endo Y; Asano T; Dong Y; Nishimoto M; Takahashi S; Fujii Y; Nakanishi R; Toyama T
Int J Clin Oncol; 2016 Jun; 21(3):539-47. PubMed ID: 26482374
[TBL] [Abstract][Full Text] [Related]
20. Sequencing of Chromosomal Locus 6q25.1 Revealed Two Significant SNPs rs2046210 and rs2046211 Associated with Breast Cancer: A Case-Control Study in Egyptian Women.
Saied MH; Rizk MM; El Sayed NAA; Mostafa SOA; Marzouk S; Fayed H
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1359-1364. PubMed ID: 35485697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
